Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 1, 2010

View Archived Issues

Preclinical activity of LY-S6KAKT1 justifies entry into phase I trial as cancer therapy

GlaxoSmithKline claims new inhibitors of focal adhesion kinase 1

High Point Pharma patents new beta-secretase 1 inhibitors

Roche describes novel inverse agonists of GABA(A) receptor

Multikinase inhibitor AI-1008 shows promise to treat chronic myeloid leukemia in preclinical testing

Phase I data presented on MEDI-573 and MEDI-575 in advanced solid tumors

Pfizer's AadAT inhibitor PF-4859989 shows activity in vivo

Atrasentan reduces albuminuria in patients with diabetes-associated nephropathy

Elan presents new antagonists of integrin alpha-4/beta-7

FDA clears design of phase III oritavancin trials SOLO-1 and -2

UCB updates progress from third quarter of 2010

Ohio State University claims new inhibitors of prostaglandin G/H synthase 2

Immunovaccine and OncoTherapy Science join to develop cancer vaccine

Renhuang Pharmaceuticals changes name to China Botanic Pharmaceutical

Optimer Pharma submits NDA for fidaxomicin to FDA and requests priority review

Pfizer's phase III axitinib trial in renal cell carcinoma meets primary endpoint

Tamir Biotechnology compounds show encouraging in vitro activity against HPV

Transition Therapeutics and Elan amend agreement on scyllo-inositol

Anacor, UCSF and LFKRI team up to discover onchocerciasis therapies

ACT files IND for phase I/II trial of MA-09-HRPE in dry AMD

NanoBio receives grant to develop vaccine against RSV infection

Savient Pharma's Krystexxa is available by prescription in U.S.

Ikaria begins pivotal phase III Lucassin trial in hepatorenal syndrome type 1

Accentia forms strategic alliance with Baxter

CBLB-502 receives FDA orphan drug status for prevention of death following irradiation

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
Neutrophils put the brakes on fat loss
BioWorld Science
Fat tissue balances energy by storing lipids during times of abundance and mobilizing them when needed, yet sustained metabolic stress demands mechanisms that...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Peptidream reveals milestone in Alnylam collaboration
BioWorld Science
Peptidream Inc. has announced a preclinical development milestone in its collaboration with Alnylam Pharmaceuticals Inc. under their siRNA conjugate discovery...